BioNeex Interviews

Clinical Stage

Interview with CEO of SilkTech Biopharmaceuticals, Brian Lawrence, PhD

Mon Apr 19 2021 22:50:35 GMT+0000 (Coordinated Universal Time)

SilkTech Biopharmaceuticals is Minneapolis based biotech company developing silk-based anti-inflammatory biotherapeutics. Currently, its lead drug candidate, Amlisimod (SDP-4) is in Phase 2 clinical trial for Dry Eye Disease.

Tags and Keywords